URICALM Trademark

Trademark Overview

On Wednesday, May 29, 2024, a trademark application was filed for URICALM with the United States Patent and Trademark Office. The USPTO has given the URICALM trademark a serial number of 98574225. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Friday, December 12, 2025. This trademark is owned by Kobayashi Pharmaceutical Co., Ltd.. The URICALM trademark is filed in the Medical Instrument Products category with the following description:

Chemically activated heat releasing patches for therapeutic purposes
uricalm

General Information

Serial Number98574225
Word MarkURICALM
Filing DateWednesday, May 29, 2024
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateFriday, December 12, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 11, 2025

Trademark Statements

Goods and ServicesChemically activated heat releasing patches for therapeutic purposes

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, May 29, 2024
Primary Code010
First Use Anywhere DateMonday, April 7, 2025
First Use In Commerce DateMonday, April 7, 2025

Trademark Owner History

Party NameKobayashi Pharmaceutical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOsaka-shi, Osaka 541-0045
JP
Party NameKobayashi Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOsaka-shi, Osaka 541-0045
JP

Trademark Events

Event DateEvent Description
Wednesday, May 29, 2024NEW APPLICATION ENTERED
Friday, December 6, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 11, 2024ASSIGNED TO EXAMINER
Wednesday, December 11, 2024NON-FINAL ACTION WRITTEN
Wednesday, December 11, 2024NON-FINAL ACTION E-MAILED
Wednesday, December 11, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 30, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 30, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 30, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 21, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 5, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 11, 2025PUBLISHED FOR OPPOSITION
Tuesday, February 11, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 8, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 27, 2025TEAS STATEMENT OF USE RECEIVED
Thursday, June 26, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 26, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 26, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 26, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, November 4, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 27, 2025USE AMENDMENT FILED
Tuesday, November 4, 2025STATEMENT OF USE PROCESSING COMPLETE
Friday, December 12, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, December 12, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

uricalm therapeutic purposes patches releasing activated heat chemically